These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12920022)

  • 61. Protective role of uncoupling protein 2 in atherosclerosis.
    Blanc J; Alves-Guerra MC; Esposito B; Rousset S; Gourdy P; Ricquier D; Tedgui A; Miroux B; Mallat Z
    Circulation; 2003 Jan; 107(3):388-90. PubMed ID: 12551860
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F; Strand DW; Rowley DR
    Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Blocking transforming growth factor beta signaling in transgenic epidermis accelerates chemical carcinogenesis: a mechanism associated with increased angiogenesis.
    Go C; Li P; Wang XJ
    Cancer Res; 1999 Jun; 59(12):2861-8. PubMed ID: 10383147
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells.
    Gorelik L; Flavell RA
    Nat Med; 2001 Oct; 7(10):1118-22. PubMed ID: 11590434
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Probing the role of homomeric and heteromeric receptor interactions in TGF-beta signaling using small molecule dimerizers.
    Stockwell BR; Schreiber SL
    Curr Biol; 1998 Jun; 8(13):761-70. PubMed ID: 9651680
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Activation of a serine/threonine kinase signaling pathway by transforming growth factor type beta.
    Atfi A; Lepage K; Allard P; Chapdelaine A; Chevalier S
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12110-4. PubMed ID: 8618854
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Regulation of TGF-beta response during T cell activation is modulated by IL-10.
    Cottrez F; Groux H
    J Immunol; 2001 Jul; 167(2):773-8. PubMed ID: 11441082
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice.
    Potteaux S; Esposito B; van Oostrom O; Brun V; Ardouin P; Groux H; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1474-8. PubMed ID: 15178562
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Activation of TGF-β receptors and Smad proteins by atorvastatin is related to reduced atherogenesis in ApoE/LDLR double knockout mice.
    Vecerova L; Strasky Z; Rathouska J; Slanarova M; Brcakova E; Micuda S; Nachtigal P
    J Atheroscler Thromb; 2012; 19(2):115-26. PubMed ID: 22104174
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transforming Growth Factor-β Signaling in Regulatory T Cells Controls T Helper-17 Cells and Tissue-Specific Immune Responses.
    Konkel JE; Zhang D; Zanvit P; Chia C; Zangarle-Murray T; Jin W; Wang S; Chen W
    Immunity; 2017 Apr; 46(4):660-674. PubMed ID: 28423340
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Transforming growth factor beta (TGF-beta)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4(+) T cell lines.
    Bridoux F; Badou A; Saoudi A; Bernard I; Druet E; Pasquier R; Druet P; Pelletier L
    J Exp Med; 1997 May; 185(10):1769-75. PubMed ID: 9151702
    [TBL] [Abstract][Full Text] [Related]  

  • 72. FcgammaRIIB inhibits the development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Zhao M; Wigren M; Dunér P; Kolbus D; Olofsson KE; Björkbacka H; Nilsson J; Fredrikson GN
    J Immunol; 2010 Mar; 184(5):2253-60. PubMed ID: 20097865
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dysregulation of IL-15-mediated T-cell homeostasis in TGF-beta dominant-negative receptor transgenic mice.
    Lucas PJ; Kim SJ; Mackall CL; Telford WG; Chu YW; Hakim FT; Gress RE
    Blood; 2006 Oct; 108(8):2789-95. PubMed ID: 16788095
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Macrophage p53 deficiency leads to enhanced atherosclerosis in APOE*3-Leiden transgenic mice.
    van Vlijmen BJ; Gerritsen G; Franken AL; Boesten LS; Kockx MM; Gijbels MJ; Vierboom MP; van Eck M; van De Water B; van Berkel TJ; Havekes LM
    Circ Res; 2001 Apr; 88(8):780-6. PubMed ID: 11325869
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Overcoming the hurdles in using mouse genetic models that block TGF-beta signaling.
    Sanjabi S; Flavell RA
    J Immunol Methods; 2010 Feb; 353(1-2):111-4. PubMed ID: 20060833
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Transforming growth factor-β: transforming plaque to stability.
    Tse K; Ley K
    Eur Heart J; 2013 Dec; 34(48):3684-6. PubMed ID: 22843445
    [No Abstract]   [Full Text] [Related]  

  • 77. [TGF-β : A key player in age-related loss of skin innate immunity].
    Gutierrez-Mateyron E; Bobé P
    Med Sci (Paris); 2021 Feb; 37(2):189-192. PubMed ID: 33591263
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Inactivation of TGF-β signaling in CAR-T cells.
    Yang Z; Fu YX
    Cell Mol Immunol; 2024 Mar; 21(3):309-310. PubMed ID: 38403679
    [No Abstract]   [Full Text] [Related]  

  • 79. Editorial: TGF-β and T cell biology.
    Soudja S; Zhang N
    Front Immunol; 2023; 14():1282656. PubMed ID: 37736097
    [No Abstract]   [Full Text] [Related]  

  • 80. Screening and validation of atherosclerosis PAN-apoptotic immune-related genes based on single-cell sequencing.
    Song Y; Lou B; Wang H; Zhang G; Xia Y; Ban R; Zhao X; Sun H; Wang J; Lin J; Guo T; Zhou J; Xia Z
    Front Immunol; 2024; 15():1297298. PubMed ID: 38736872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.